U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Alveolar soft part sarcoma(ASPS)

MedGen UID:
61652
Concept ID:
C0206657
Neoplastic Process
Synonyms: Alveolar soft part sarcoma (disease); ASPS
SNOMED CT: Alveolar soft part sarcoma (88195001); Alveolar soft part sarcoma (404056007)
Modes of inheritance:
Not genetically inherited
MedGen UID:
988794
Concept ID:
CN307044
Finding
Source: Orphanet
clinical entity without genetic inheritance.
 
Gene (location): ASPSCR1 (17q25.3)
 
HPO: HP:0012218
Monarch Initiative: MONDO:0011655
OMIM®: 606243
Orphanet: ORPHA163699

Definition

Alveolar soft part sarcoma is an unusual tumor with highly characteristic histopathology and ultrastructure, controversial histogenesis, and enigmatic clinical behavior (Lieberman et al., 1989; Ordonez, 1999). The typical histology of ASPS shows well-defined nests of cells with abundant pink cytoplasm. The loss of central cohesion produces a pseudoalveolar appearance (Ladanyi et al., 2001). [from OMIM]

Clinical features

From HPO
Alveolar soft part sarcoma
MedGen UID:
61652
Concept ID:
C0206657
Neoplastic Process
Alveolar soft part sarcoma is an unusual tumor with highly characteristic histopathology and ultrastructure, controversial histogenesis, and enigmatic clinical behavior (Lieberman et al., 1989; Ordonez, 1999). The typical histology of ASPS shows well-defined nests of cells with abundant pink cytoplasm. The loss of central cohesion produces a pseudoalveolar appearance (Ladanyi et al., 2001).

Conditions with this feature

Alveolar soft part sarcoma
MedGen UID:
61652
Concept ID:
C0206657
Neoplastic Process
Alveolar soft part sarcoma is an unusual tumor with highly characteristic histopathology and ultrastructure, controversial histogenesis, and enigmatic clinical behavior (Lieberman et al., 1989; Ordonez, 1999). The typical histology of ASPS shows well-defined nests of cells with abundant pink cytoplasm. The loss of central cohesion produces a pseudoalveolar appearance (Ladanyi et al., 2001).

Professional guidelines

PubMed

Crombé A, Roulleau-Dugage M, Italiano A
Cancer Commun (Lond) 2022 Dec;42(12):1288-1313. Epub 2022 Oct 19 doi: 10.1002/cac2.12373. PMID: 36260064Free PMC Article
Saerens M, Brusselaers N, Rottey S, Decruyenaere A, Creytens D, Lapeire L
Eur J Cancer 2021 Jul;152:165-182. Epub 2021 Jun 6 doi: 10.1016/j.ejca.2021.04.034. PMID: 34107450
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044

Recent clinical studies

Etiology

Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T
Int J Clin Oncol 2023 Jan;28(1):1-11. Epub 2022 Jan 27 doi: 10.1007/s10147-022-02119-7. PMID: 35084598
Crombé A, Roulleau-Dugage M, Italiano A
Cancer Commun (Lond) 2022 Dec;42(12):1288-1313. Epub 2022 Oct 19 doi: 10.1002/cac2.12373. PMID: 36260064Free PMC Article
Dajsakdipon T, Siripoon T, Ngamphaiboon N, Ativitavas T, Dejthevaporn T
Curr Treat Options Oncol 2022 Mar;23(3):415-438. Epub 2022 Mar 9 doi: 10.1007/s11864-022-00944-6. PMID: 35262852
Nakata E, Fujiwara T, Kunisada T, Ito T, Takihira S, Ozaki T
Jpn J Clin Oncol 2021 Apr 1;51(4):523-537. doi: 10.1093/jjco/hyab005. PMID: 33611603
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044

Diagnosis

Crombé A, Roulleau-Dugage M, Italiano A
Cancer Commun (Lond) 2022 Dec;42(12):1288-1313. Epub 2022 Oct 19 doi: 10.1002/cac2.12373. PMID: 36260064Free PMC Article
Argani P, Wobker SE, Gross JM, Matoso A, Fletcher CDM, Antonescu CR
Am J Surg Pathol 2022 Aug 1;46(8):1153-1159. Epub 2022 Apr 5 doi: 10.1097/PAS.0000000000001894. PMID: 35848761Free PMC Article
Dajsakdipon T, Siripoon T, Ngamphaiboon N, Ativitavas T, Dejthevaporn T
Curr Treat Options Oncol 2022 Mar;23(3):415-438. Epub 2022 Mar 9 doi: 10.1007/s11864-022-00944-6. PMID: 35262852
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044
Ray-Coquard I, Serre D, Reichardt P, Martín-Broto J, Bauer S
Future Oncol 2018 May;14(10s):25-49. doi: 10.2217/fon-2018-0076. PMID: 29768052

Therapy

Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P
Lancet Oncol 2022 Sep;23(9):1156-1166. Epub 2022 Aug 4 doi: 10.1016/S1470-2045(22)00392-8. PMID: 35934010
Zhu MMT, Shenasa E, Nielsen TO
Cancer Treat Rev 2020 Dec;91:102115. Epub 2020 Oct 20 doi: 10.1016/j.ctrv.2020.102115. PMID: 33130422
Wilky BA, Trucco MM, Subhawong TK, Florou V, Park W, Kwon D, Wieder ED, Kolonias D, Rosenberg AE, Kerr DA, Sfakianaki E, Foley M, Merchan JR, Komanduri KV, Trent JC
Lancet Oncol 2019 Jun;20(6):837-848. Epub 2019 May 8 doi: 10.1016/S1470-2045(19)30153-6. PMID: 31078463
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044
Ray-Coquard I, Serre D, Reichardt P, Martín-Broto J, Bauer S
Future Oncol 2018 May;14(10s):25-49. doi: 10.2217/fon-2018-0076. PMID: 29768052

Prognosis

Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T
Int J Clin Oncol 2023 Jan;28(1):1-11. Epub 2022 Jan 27 doi: 10.1007/s10147-022-02119-7. PMID: 35084598
Dajsakdipon T, Siripoon T, Ngamphaiboon N, Ativitavas T, Dejthevaporn T
Curr Treat Options Oncol 2022 Mar;23(3):415-438. Epub 2022 Mar 9 doi: 10.1007/s11864-022-00944-6. PMID: 35262852
Nakata E, Fujiwara T, Kunisada T, Ito T, Takihira S, Ozaki T
Jpn J Clin Oncol 2021 Apr 1;51(4):523-537. doi: 10.1093/jjco/hyab005. PMID: 33611603
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044
Ray-Coquard I, Serre D, Reichardt P, Martín-Broto J, Bauer S
Future Oncol 2018 May;14(10s):25-49. doi: 10.2217/fon-2018-0076. PMID: 29768052

Clinical prediction guides

Crombé A, Roulleau-Dugage M, Italiano A
Cancer Commun (Lond) 2022 Dec;42(12):1288-1313. Epub 2022 Oct 19 doi: 10.1002/cac2.12373. PMID: 36260064Free PMC Article
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A
Surg Oncol Clin N Am 2022 Jul;31(3):381-397. doi: 10.1016/j.soc.2022.03.004. PMID: 35715140
Dajsakdipon T, Siripoon T, Ngamphaiboon N, Ativitavas T, Dejthevaporn T
Curr Treat Options Oncol 2022 Mar;23(3):415-438. Epub 2022 Mar 9 doi: 10.1007/s11864-022-00944-6. PMID: 35262852
Nakata E, Fujiwara T, Kunisada T, Ito T, Takihira S, Ozaki T
Jpn J Clin Oncol 2021 Apr 1;51(4):523-537. doi: 10.1093/jjco/hyab005. PMID: 33611603
Paoluzzi L, Maki RG
JAMA Oncol 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490. PMID: 30347044

Recent systematic reviews

Yang Y, Beeraka NM, Liu J, Zuo X, Wang X, Li T, Fan R
Curr Pharm Des 2022;28(41):3404-3412. doi: 10.2174/1381612828666220921151750. PMID: 36154597
Saerens M, Brusselaers N, Rottey S, Decruyenaere A, Creytens D, Lapeire L
Eur J Cancer 2021 Jul;152:165-182. Epub 2021 Jun 6 doi: 10.1016/j.ejca.2021.04.034. PMID: 34107450

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...